Login to Your Account



Cinrx snags $10M series B to back gastrointestinal-focused pipeline

By Michael Fitzhugh
Staff Writer

Tuesday, November 28, 2017

Cincinnati-based Cinrx Pharma LLC, a company advancing four early stage candidates for gastrointestinal, cardiovascular and dermatologic indications, has completed a $10 million series B financing backed by both current and new investors.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription